Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Download these slides from a live webinar for the most recent data on the best methods for molecular testing in NSCLC, including information on different testing methodologies, platforms, and assays as well as considerations for clinical practices and socioeconomic disparities.

Narjust Duma, MD Released: June 5, 2022

Download these slides from a live webinar for a review of recent data on treatment selection for patients with EGFR, KRAS, or HER2-positive NSCLC.

Karen L. Reckamp, MD, MS Released: June 5, 2022

Download these slides from a live webinar for the most recent data on optimal treatment approaches for patients with NSCLC that are positive for less common driver mutations, including MET, RET, ALK, ROS, and NTRK.

Todd M. Bauer, MD Released: June 5, 2022

In this on-demand webcast from a live symposium, oncology experts Todd M. Bauer; MD, Narjust Duma, MD; and Karen L. Reckamp, MD, MS discuss current and emerging data on biomarker testing and targeted therapy for the treatment of patients with NSCLC.

Todd M. Bauer, MD Narjust Duma, MD Karen L. Reckamp, MD, MS Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: June 7, 2022 Expired: No longer available for credit

Narjust Florez, MD, describes 2 patient case examples from her practice to highlight the importance of biomarker testing for patients with NSCLC.

Narjust Duma, MD Released: September 23, 2022